vs
奥驰亚（MO）与PETMED EXPRESS INC（PETS）财务数据对比。点击上方公司名可切换其他公司
奥驰亚的季度营收约是PETMED EXPRESS INC的143.8倍（$5.8B vs $40.7M）。奥驰亚净利率更高（19.1% vs -26.0%，领先45.1%）。奥驰亚同比增速更快（-2.1% vs -23.3%）。奥驰亚自由现金流更多（$3.2B vs $-9.2M）。过去两年奥驰亚的营收复合增速更高（2.4% vs -20.9%）
奥驰亚集团是美国头部烟草企业，通过旗下子公司生产销售可燃烟草与口服类烟草相关产品，核心品牌包括万宝路香烟、Black & Mild雪茄及烟斗烟、哥本哈根、斯库尔等湿无烟烟草，以及on!口服尼古丁袋，产品主要供应批发商、分销商及大型零售客户。
PetMed Express，也叫PetMeds，是总部位于美国的线上宠物药房。该企业公开上市，主营宠物处方及非处方药物销售业务，是北美知名的宠物医药线上零售平台。
MO vs PETS — 直观对比
营收规模更大
MO
是对方的143.8倍
$40.7M
营收增速更快
MO
高出21.1%
-23.3%
净利率更高
MO
高出45.1%
-26.0%
自由现金流更多
MO
多$3.2B
$-9.2M
两年增速更快
MO
近两年复合增速
-20.9%
损益表 — Q4 2025 vs Q3 2026
| 指标 | | |
|---|---|---|
| 营收 | $5.8B | $40.7M |
| 净利润 | $1.1B | $-10.6M |
| 毛利率 | 62.1% | 23.3% |
| 营业利润率 | 28.2% | -25.7% |
| 净利率 | 19.1% | -26.0% |
| 营收同比 | -2.1% | -23.3% |
| 净利润同比 | -63.2% | -1392.6% |
| 每股收益（稀释后） | $0.67 | $-0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MOPETS
| Q4 25 | $5.8B | $40.7M | ||
| Q3 25 | $6.1B | $44.4M | ||
| Q2 25 | $6.1B | $51.2M | ||
| Q1 25 | $5.3B | $50.8M | ||
| Q4 24 | $6.0B | $52.0M | ||
| Q3 24 | $6.3B | $58.0M | ||
| Q2 24 | $6.2B | $66.2M | ||
| Q1 24 | $5.6B | $65.1M |
净利润MOPETS
| Q4 25 | $1.1B | $-10.6M | ||
| Q3 25 | $2.4B | $-8.5M | ||
| Q2 25 | $2.4B | $-34.2M | ||
| Q1 25 | $1.1B | $-11.6M | ||
| Q4 24 | $3.0B | $-707.0K | ||
| Q3 24 | $2.3B | $2.3M | ||
| Q2 24 | $3.8B | $3.8M | ||
| Q1 24 | $2.1B | $-5.0M |
毛利率MOPETS
| Q4 25 | 62.1% | 23.3% | ||
| Q3 25 | 62.8% | 28.0% | ||
| Q2 25 | 63.1% | 28.1% | ||
| Q1 25 | 61.8% | 29.9% | ||
| Q4 24 | 60.3% | 31.0% | ||
| Q3 24 | 60.8% | 32.3% | ||
| Q2 24 | 59.2% | 28.8% | ||
| Q1 24 | 58.8% | 29.3% |
营业利润率MOPETS
| Q4 25 | 28.2% | -25.7% | ||
| Q3 25 | 53.2% | -18.9% | ||
| Q2 25 | 52.9% | -66.7% | ||
| Q1 25 | 34.0% | -11.9% | ||
| Q4 24 | 48.2% | -0.9% | ||
| Q3 24 | 50.4% | 1.0% | ||
| Q2 24 | 40.8% | 6.6% | ||
| Q1 24 | 48.0% | -5.9% |
净利率MOPETS
| Q4 25 | 19.1% | -26.0% | ||
| Q3 25 | 39.1% | -19.2% | ||
| Q2 25 | 39.0% | -66.7% | ||
| Q1 25 | 20.5% | -22.9% | ||
| Q4 24 | 50.9% | -1.4% | ||
| Q3 24 | 36.6% | 4.0% | ||
| Q2 24 | 61.2% | 5.7% | ||
| Q1 24 | 38.2% | -7.7% |
每股收益（稀释后）MOPETS
| Q4 25 | $0.67 | $-0.50 | ||
| Q3 25 | $1.41 | $-0.41 | ||
| Q2 25 | $1.41 | $-1.65 | ||
| Q1 25 | $0.63 | $-0.56 | ||
| Q4 24 | $1.78 | $-0.03 | ||
| Q3 24 | $1.34 | $0.11 | ||
| Q2 24 | $2.21 | $0.18 | ||
| Q1 24 | $1.21 | $-0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | $26.9M |
| 总债务越低越好 | $25.7B | — |
| 股东权益账面价值 | $-3.5B | $32.8M |
| 总资产 | $35.0B | $88.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MOPETS
| Q4 25 | $4.5B | $26.9M | ||
| Q3 25 | $3.5B | $36.1M | ||
| Q2 25 | $1.3B | $41.1M | ||
| Q1 25 | $4.7B | $54.7M | ||
| Q4 24 | $3.1B | $50.1M | ||
| Q3 24 | $1.9B | $52.0M | ||
| Q2 24 | $1.8B | $46.0M | ||
| Q1 24 | $3.6B | $55.3M |
总债务MOPETS
| Q4 25 | $25.7B | — | ||
| Q3 25 | $25.7B | — | ||
| Q2 25 | $24.7B | — | ||
| Q1 25 | $26.1B | — | ||
| Q4 24 | $24.9B | — | ||
| Q3 24 | $25.2B | — | ||
| Q2 24 | $25.0B | — | ||
| Q1 24 | $25.0B | — |
股东权益MOPETS
| Q4 25 | $-3.5B | $32.8M | ||
| Q3 25 | $-2.6B | $43.1M | ||
| Q2 25 | $-3.3B | $51.5M | ||
| Q1 25 | $-3.5B | $85.1M | ||
| Q4 24 | $-2.2B | $96.2M | ||
| Q3 24 | $-3.5B | $96.4M | ||
| Q2 24 | $-3.0B | $93.5M | ||
| Q1 24 | $-5.1B | $96.7M |
总资产MOPETS
| Q4 25 | $35.0B | $88.0M | ||
| Q3 25 | $35.0B | $100.3M | ||
| Q2 25 | $32.3B | $109.8M | ||
| Q1 25 | $35.8B | $148.7M | ||
| Q4 24 | $35.2B | $144.8M | ||
| Q3 24 | $34.2B | $146.0M | ||
| Q2 24 | $34.4B | $152.7M | ||
| Q1 24 | $36.5B | $169.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.3B | $-9.2M |
| 自由现金流经营现金流 - 资本支出 | $3.2B | $-9.2M |
| 自由现金流率自由现金流/营收 | 54.4% | -22.7% |
| 资本支出强度资本支出/营收 | 1.6% | 0.1% |
| 现金转化率经营现金流/净利润 | 2.93× | — |
| 过去12个月自由现金流最近4个季度 | $9.1B | $-23.0M |
8季度趋势，按日历期对齐
经营现金流MOPETS
| Q4 25 | $3.3B | $-9.2M | ||
| Q3 25 | $3.1B | $-2.2M | ||
| Q2 25 | $205.0M | $-12.3M | ||
| Q1 25 | $2.7B | $7.0M | ||
| Q4 24 | $3.3B | $-1.2M | ||
| Q3 24 | $2.6B | $7.4M | ||
| Q2 24 | $-75.0M | $-8.5M | ||
| Q1 24 | $2.9B | $7.1M |
自由现金流MOPETS
| Q4 25 | $3.2B | $-9.2M | ||
| Q3 25 | $3.0B | $-4.8M | ||
| Q2 25 | $173.0M | $-13.6M | ||
| Q1 25 | $2.7B | $4.6M | ||
| Q4 24 | $3.3B | $-1.9M | ||
| Q3 24 | $2.6B | $6.1M | ||
| Q2 24 | $-104.0M | $-9.2M | ||
| Q1 24 | $2.8B | $5.9M |
自由现金流率MOPETS
| Q4 25 | 54.4% | -22.7% | ||
| Q3 25 | 50.1% | -10.8% | ||
| Q2 25 | 2.8% | -26.5% | ||
| Q1 25 | 51.0% | 9.1% | ||
| Q4 24 | 55.1% | -3.7% | ||
| Q3 24 | 41.2% | 10.6% | ||
| Q2 24 | -1.7% | -13.9% | ||
| Q1 24 | 51.0% | 9.0% |
资本支出强度MOPETS
| Q4 25 | 1.6% | 0.1% | ||
| Q3 25 | 0.9% | 5.9% | ||
| Q2 25 | 0.5% | 2.5% | ||
| Q1 25 | 0.7% | 4.7% | ||
| Q4 24 | 0.8% | 1.5% | ||
| Q3 24 | 0.5% | 2.2% | ||
| Q2 24 | 0.5% | 1.0% | ||
| Q1 24 | 0.6% | 1.9% |
现金转化率MOPETS
| Q4 25 | 2.93× | — | ||
| Q3 25 | 1.30× | — | ||
| Q2 25 | 0.09× | — | ||
| Q1 25 | 2.53× | — | ||
| Q4 24 | 1.10× | — | ||
| Q3 24 | 1.14× | 3.18× | ||
| Q2 24 | -0.02× | -2.27× | ||
| Q1 24 | 1.35× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MO
| Smokeable Products Segment | $5.1B | 88% |
| Oral Tobacco Segment | $706.0M | 12% |
PETS
| Reorder | $34.0M | 84% |
| New Order | $5.0M | 12% |
| Membership Fees | $1.6M | 4% |
